BioSpace News Archive

Deals

Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates

Boehringer Ingelheim today announced the signing of a binding agreement for acquiring all shares of NBE-Therapeutics, a private, clinical-stage Swiss biotechnology company focused on antibody-drug conjugates and advancing targeted cancer therapies derived from its immune stimulatory iADC™ platform.

December 10, 2020
·
3 min read
Drug Development

Ultimovacs Announces Positive 5-Year Overall Survival Update from Phase I Combination Trial Evaluating Universal Cancer Vaccine UV1 in Metastatic Melanoma

Ultimovacs ASA, announced positive five-year Overall Survival data from the Phase I trial evaluating the company’s universal cancer vaccine, UV1, in combination with the checkpoint inhibitor, ipilimumab, in patients with metastatic malignant melanoma.

December 10, 2020
·
5 min read
Calliditas wins the 2020 SwedenBio Award

The winner of this year’s SwedenBIO Award was announced on Wednesday December 9th. Calliditas Therapeutics AB received the award in recognition of its successful clinical development program of Nefecon, which culminated in the recent positive topline data readout of the pivotal Phase 3 NefIgArd trial.

December 10, 2020
·
2 min read
Pharm Country

Results from First Combination Trial of ENHERTU® and Immune Checkpoint Inhibitor in Patients with HER2 Expressing Metastatic Breast Cancer Presented at the 2020 San Antonio Breast Cancer Symposium

Initial results demonstrate ENHERTU may be safely combined with nivolumab, an immune checkpoint inhibitor in patients with HER2 positive or HER2 low metastatic breast cancer

December 10, 2020
·
19 min read
Alligator Bioscience launches ALLIGATOR-FAB™ - a novel human antibody library

Alligator Bioscience announced the completion of a novel proprietary human synthetic antibody library in Fab format - ALLIGATOR-FAB™.

December 10, 2020
·
2 min read
FDA

Advanced Bionics Receives FDA Approval for Marvel Cochlear Implant Platform and World’s First Sound Processor for Children

Advanced Bionics, a global leader in cochlear implant technology, in collaboration with Phonak, a leading provider of life-changing hearing solutions, receives FDA approval and announces it is bringing Marvel hearing technology to Advanced Bionics cochlear implant wearers.

December 10, 2020
·
8 min read
Business

Biofidelity appoints Robert Osborne as Chief Operating Officer

Biofidelity Ltd, the cancer diagnostics company, announces the further expansion of its leadership team with the appointment of Dr. Robert Osborne as Chief Operating Officer.

December 10, 2020
·
4 min read
Drug Development

Apellis and Sobi Report Positive Top-line Results at 48 Weeks from the Phase 3 PEGASUS Study of Pegcetacoplan in PNH

Treatment with pegcetacoplan resulted in a sustained improvement in hemoglobin with a mean increasefrom baseline of 2.7g/dLat Week 48, which isequal tothe2.7 g/dL increaseseen at Week 16 with pegcetacoplan-treated patients

December 10, 2020
·
9 min read
Biotech Beach

Decentralized Trials & Research Alliance (DTRA) Launches to Democratize and Accelerate Clinical Trials

A historic alliance of life sciences and healthcare organizations seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.

December 10, 2020
·
2 min read
BioCapital

Net Health’s New Mobile Immunization Tracking Provides Safe and Effective Solution for COVID-19 Vaccination Administration

Net Health has developed a proprietary web-based Mobile Immunization Tracking platform to more efficiently manage on-site immunizations.

December 10, 2020
·
2 min read